Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kronel Gel is a topical phytotherapeutic (botanical) medication developed and manufactured by Hebron Nutrition (Hebron Farmacêutica). The active ingredient is an extract derived from the bark of *Schinus terebinthifolia* Raddi, commonly known as the Brazilian pepper tree or Aroeira. It is primarily indicated for the treatment of gynecological conditions, including cervicitis, colpitis (vaginitis), and other inflammatory or infectious processes of the female genital tract. The therapeutic efficacy of Kronel Gel is attributed to its high concentration of tannins, which provide potent anti-inflammatory, antimicrobial, and cicatrizing (wound-healing) properties. By precipitating proteins on the surface of the vaginal mucosa, it forms a protective layer that aids in tissue regeneration and inhibits the proliferation of pathogens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on schinus terebinthifolia extract.